Results 261 to 270 of about 274,715 (359)
Rho GTPases as therapeutic targets in cancer (Review)
Georgina A. Cardama +4 more
openalex +2 more sources
ABSTRACT Insulin secretion is a complex, vesicular transport process. Rab34 is a key regulator of intracellular vesicle transport; however, its role in insulin secretion has not yet been reported. miRNA‐9 is vital for the development and progression of the diagnosis and treatment of type 2 diabetes. This study aimed to investigate whether miR‐9 targets
Zhen‐Zhen Guo +5 more
wiley +1 more source
Role of FlhF and its domains in the assembly of a polar flagellum in <i>P. aeruginosa</i>. [PDF]
Raghav S, Prajapati R, Jain D.
europepmc +1 more source
ABSTRACT Molecular diagnostics have become an important adjunct to ultrasonography and fine‐needle aspiration (FNA) for thyroid nodules, especially in Bethesda III/IV cytology where malignancy risk is uncertain. This narrative review summarizes the diagnostic and prognostic value of key genomic drivers (BRAF V600E, RAS, RET, TERT, and selected fusions)
Guohui Xiao +14 more
wiley +1 more source
Where and how many: evolutionary diversification of a molecular switch regulating flagellar patterns. [PDF]
Bange G +3 more
europepmc +1 more source
Abstract Background Transsynaptic α‐synuclein propagation plays a crucial role in the progression of Lewy body disease. We previously demonstrated that an α‐amino‐3‐hydroxy‐5‐methyl‐4‐isoxazolepropionic acid receptor antagonist, perampanel, blocks neuronal uptake of α‐synuclein preformed fibrils (PFFs) in an activity‐dependent manner.
Jun Ueda +9 more
wiley +1 more source
Control of lysosome function by the GTPase-activating protein TBC1D9B and its binding partner TMEM55B. [PDF]
Duhay V +12 more
europepmc +1 more source
Refractory Lung Diseases: From Cellular Structures, Molecular Mechanisms to Therapeutic Strategies
ABSTRACT Refractory lung diseases (RLDs) encompass a spectrum of progressive pulmonary disorders, including acute respiratory distress syndrome (ARDS), bronchopulmonary dysplasia (BPD), and idiopathic pulmonary fibrosis (IPF). These conditions are defined by poor responsiveness to current therapeutic interventions and pose substantial clinical ...
Yiheng Qiu +12 more
wiley +1 more source

